Pascal Mettens

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

Steven G. Reed, Rhea N. Coler, Wilfried Dalemans et al. · Proceedings of the National Academy of Sciences · 2009 · 165 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial

Isabel Leroux‐Roels, Sheron Forgus, Fien De Boever et al. · Vaccine · 2012 · 160 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

Cheryl L. Day, Michèle Tameris, Nazma Mansoor et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 119 citations

Life Sciences, Immunology, Infectious Diseases +17

Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity to<i>Plasmodium falciparum</i>CS Compared to That with Either Malaria Vaccine Alone

V. Ann Stewart, Shannon McGrath, Patrice Dubois et al. · Infection and Immunity · 2007 · 103 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

Jaime Montoya, Juan Antonio Solon, Soledad Rosanna C. Cunanan et al. · Journal of Clinical Immunology · 2013 · 98 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17